Ignite Creation Date:
2024-05-06 @ 7:28 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02543411
Status:
COMPLETED
Last Update Posted:
2015-12-15
First Post:
2015-09-02
Brief Title:
Use of Lidocaine in Endoscopic Submucosal Dissection
Sponsor:
Severance Hospital
Organization:
Severance Hospital
Study Overview
Official Title:
Effect of Intravenous Lidocaine During Endoscopic Submucosal Dissection for Gastric Neoplasm
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to investigate the effects of lidocaine on the total administered dose of fentanyl during sedation for endoscopic mucosal resection
The secondary purpose of this study is to investigate the effects of lidocaine on pain score related with endoscopic mucosal resection at time of 30 min 6 hr and 24 hr after procedure
The secondary purpose of this study is to investigate the effects of lidocaine on pain score related with endoscopic mucosal resection at time of 30 min 6 hr and 24 hr after procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None